Dr. Colin Hayward has been named European Medical Director at Premier Research Group. Dr. Hayward will be responsible for leading and developing the company’s European medical affairs and pharmacovigilance operations.
 
“Dr. Hayward brings medical expertise, clinical knowledge, leadership, and a wealth of experience in key areas important to our customers and will provide an added level of therapeutic insight to Premier’s services,” said Dr. Sue Stansfield, executive vice president, Clinical Development. “He will be a tremendous asset for both employees and customers and is a welcome addition to our strong team in Europe.”
 
Dr. Hayward is a board certified pharmaceutical physician with 12 years international experience in pharmacovigilance, design and implementation of clinical programs and medical affairs. Before joining Roche pharmacovigilance and quickly progressing through a series of positions with increasing responsibility to International Medical Leader, Dr Hayward practiced in the UK Health Service in anesthesia and intensive care. Most recently Dr Hayward was Director of Prism Ideas Ltd., with responsibility for the medical team of this pharmaceutical medicine consultancy.